Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Cardiol. 2010 Jul;33(7):430-8. doi: 10.1002/clc.20795.

Long-term outcome of 4 Korean families with hypertrophic cardiomyopathy caused by 4 different mutations.

Author information

  • 1Division of Cardiology, Department of Medicine, Cardiac and Vascular Centre, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Abstract

BACKGROUND:

We sought to describe the long-term outcome of individuals in 4 Korean families with hypertrophic cardiomyopathy (HCM) with known mutations.

HYPOTHESIS:

Long-term clinical features of familial HCM might be characterized according to the mutation causing HCM.

METHODS:

We performed long-term (mean, 13.1 y) clinical evaluations on 46 subjects from 4 Korean families with different mutations.

RESULTS:

Myosin light chain 3 gene (MYL3) mutation was associated with late-onset HCM with relatively poor prognosis; 1 sudden cardiac death and 2 cases of heart failure with atrial fibrillation occurred among 12 subjects with this mutation. Myosin binding protein C gene (MYBPC3) mutation was associated with 2 cases of sudden cardiac death and 3 cases of heart failure among 7 affected members. Cardiac troponin I type 3 gene (TNNI3) mutation was associated with 5 deaths related to atrial fibrillation and stroke among 12 mutation-positive members. Myosin heavy chain 7 gene (MYH7) mutation was associated with 11 deaths in 15 affected members.

CONCLUSIONS:

The clinical course was quite different for different HCM mutations. Even within the same family, individuals carrying the same mutation differed in disease expression and prognosis.

Copyright (c) 2010 Wiley Periodicals, Inc.

PMID:
20641121
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk